11/24
08:43 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
11/24
08:43 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $50.00 price target on the stock.
11/24
08:21 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
11/24
08:21 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
11/11
09:54 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/11
09:54 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/10
02:04 pm
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
11/10
02:04 pm
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush.
11/5
10:06 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
10:06 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
09:55 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
11/5
09:55 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
10/29
12:51 pm
anab
Rating for ANAB
Medium
Report
Rating for ANAB
10/15
11:10 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
10/15
11:10 am
anab
Rating for ANAB
Medium
Report
Rating for ANAB
10/13
08:00 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
10/13
08:00 am
anab
Rating for ANAB
Low
Report
Rating for ANAB
10/13
05:24 am
anab
AnaptysBio initiated with an Overweight at Barclays
Medium
Report
AnaptysBio initiated with an Overweight at Barclays
10/13
05:24 am
anab
AnaptysBio initiated with an Overweight at Barclays
Medium
Report
AnaptysBio initiated with an Overweight at Barclays
9/30
08:55 am
anab
Rating for ANAB
High
Report
Rating for ANAB
9/30
08:55 am
anab
Rating for ANAB
High
Report
Rating for ANAB
9/30
08:05 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
High
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
9/30
08:05 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
High
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
9/16
07:14 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
Medium
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
9/16
07:14 am
anab
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
Medium
Report
AnaptysBio (NASDAQ:ANAB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.